Interestingly, the inhibition of mGluR1 signaling was associated with the downregulation of the PI3K/AKT/mTOR signaling pathway, indicating that mGluR1 affects glioma via this signaling pathway (59). This evidence concerns the gene GRM1 and central nervous system cancer.